Andrew Cheng, M.D., Ph.D.
Member
- Year of birth 1967
- Nationality US-American
- Place of residence Burlingame, CA, USA
- Initial appointment 2022
- End of current period 2025
Professional Development
Since 2018 President and Chief Executive Officer of Akero Therapeutics, Inc., South San Francisco, CA
2018 Chief Medical Officer, Executive Vice President at Gilead Sciences, Foster City, CA
2015 - 2018 Executive Vice President, Clinical Research and Development Operations, Gilead Sciences, Foster City, CA
2009 - 2015 Senior Vice President, Clinical Research and Development Operations,Gilead Sciences, Foster City, CA
2005 - 2009 Vice President, Clinical Research, Gilead Sciences, Foster City, CA
2004 - 2005 Senior Director, Clinical Research, Gilead Sciences, Foster City, CA
2002 - 2004 Director, Clinical Research, Gilead Sciences, Foster City, CA
1999 - 2002 Associate Director, Clinical Research, Gilead Sciences, Foster City, CA
Education
1996 M.D., Columbia University, College of Physicians and Surgeons, Medical Scientist Training Program (M.D.-Ph.D. Program), NY, NY
1995 Ph.D., Columbia University, College of Physicians and Surgeons, Integrated Program Genetics and Biochemistry, NY, NY
1988 B.A. Honors, Johns Hopkins University, Baltimore, MD (Biology)
Memberships in Statutory Supervisory Boards and/or in Comparable Domestic or Foreign Supervisory Bodies of Commercial Enterprises Section
Vera Therapeutics, Inc., Brisbane, California, USA Member of the Board of Directors